Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.035 USD | -2.78% | 0.00% | -95.00% |
04-11 | North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge | DJ |
04-04 | North American Morning Briefing : Focus Turns to -2- | DJ |
Sales 2021 | 2.21M 177M | Sales 2022 | 4.76M 381M | Capitalization | 25.39M 2.03B |
---|---|---|---|---|---|
Net income 2021 | -45M -3.6B | Net income 2022 | -26M -2.08B | EV / Sales 2021 | 31.5 x |
Net cash position 2021 | 20.53M 1.64B | Net cash position 2022 | 433K 34.68M | EV / Sales 2022 | 5.25 x |
P/E ratio 2021 |
-1.9
x | P/E ratio 2022 |
-0.96
x | Employees | 12 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 90.68% |
Latest transcript on DMK Pharmaceuticals Corporation
1 day | -2.78% | ||
Current month | -32.69% | ||
1 month | -42.15% | ||
3 months | -93.52% | ||
6 months | -93.23% | ||
Current year | -95.00% |
Managers | Title | Age | Since |
---|---|---|---|
Ebrahim Versi
CEO | Chief Executive Officer | 71 | 24/05/23 |
Seth Cohen
DFI | Director of Finance/CFO | 42 | 15/10/23 |
Robert H. Uhl
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Howard Birndorf
BRD | Director/Board Member | 74 | 25/08/19 |
Ebrahim Versi
CEO | Chief Executive Officer | 71 | 24/05/23 |
Vickie Reed
BRD | Director/Board Member | 62 | 23/05/22 |
Date | Price | Change | Volume |
---|---|---|---|
01/05/24 | 0.035 | -2.78% | 13 759 |
30/04/24 | 0.036 | +2.86% | 32,092 |
29/04/24 | 0.035 | 0.00% | 13,860 |
26/04/24 | 0.035 | -2.78% | 143,836 |
25/04/24 | 0.036 | -14.29% | 35,977 |
Delayed Quote OTC Markets, May 01, 2024 at 04:56 pm
More quotes1st Jan change | Capi. | |
---|---|---|
-95.00% | 363K | |
+32.95% | 704B | |
+28.59% | 577B | |
-3.64% | 348B | |
+18.38% | 327B | |
+5.49% | 288B | |
+14.81% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.01% | 147B |
- Stock Market
- Equities
- DMKPQ Stock